Conduction defects after coronary artery bypass grafting--a disappearing problem?

P Mustonen1, M Pöyhönen, S Rehnberg

  • 1Department of Surgery, Kuopio University Hospital, Finland. paula_k.mustonen@kuh.fi

Annales Chirurgiae Et Gynaecologiae
|May 3, 2000
PubMed

Insights

Improved cardiac surgery techniques significantly reduced conduction defects after coronary artery bypass grafting (CABG). This advancement protects both heart muscle and conduction tissues, leading to better patient outcomes.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Electrophysiology

Background:

  • Conduction defects (CDs) are a known complication following coronary artery bypass grafting (CABG).
  • The incidence and etiologic factors of CDs post-CABG require further investigation.
  • The impact of CDs on immediate postoperative outcomes needs to be understood.

Purpose of the Study:

  • To evaluate the incidence of conduction defects (CDs) after coronary artery bypass grafting (CABG) in three distinct patient cohorts.
  • To identify etiologic factors associated with the development of CDs following CABG.
  • To assess the effect of CDs on immediate postoperative outcomes in patients undergoing CABG.

Main Methods:

  • Prospective study of three cohorts (n=180, n=100, n=118) undergoing CABG between 1990-1997.
  • Utilized cold crystalloid cardioplegia with varying techniques for myocardial protection and proximal anastomosis.
  • Methods included dual cava cannulation, right upper pulmonary vein venting, iced saline pericardial cooling, and specific cardioplegia delivery protocols.

Main Results:

  • Incidence of permanent CDs decreased dramatically: 36% (cohort A), 5% (cohort B), and 1% (cohort C).
  • Left main coronary artery stenosis and low myocardial temperatures were linked to CDs.
  • Patients with permanent CDs experienced higher rates of low cardiac output, elevated cardiac enzymes, and postoperative infarction.

Conclusions:

  • Improved myocardial protection strategies led to a significant reduction in postoperative conduction defects.
  • The disappearance of blocks correlated with decreasing cardiac enzyme levels, indicating better protection of conduction tissue and myocardium.
  • Optimized cardioplegia administration and temperature management were key factors in preventing postoperative CDs.
Abstract

Related Concept Videos

Conduction System of the Heart01:19

Conduction System of the Heart

Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
Conduction System of the Heart01:20

Conduction System of the Heart

The cardiac conduction system produces and transmits electrical impulses that prompt myocardial contraction, ensuring efficient heart function. This intricate system ensures that the heart beats in a coordinated and efficient manner, beginning with the atria and then the ventricles. The conduction system optimizes cardiac output by maintaining this precise sequence, which is crucial for adequate blood circulation.
This system relies on the unique properties of nodal and Purkinje cells:...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...